FDA Brief

Company record

Brandywine Pharmaceuticals, LLC

0 FDA warning letters since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about Brandywine Pharmaceuticals, LLC.

Recalls

ReportedClassFirmProduct and reason
Nov 4 Class II Brandywine Pharmaceuticals, LLC
Drug
Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-500-10
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
Nov 4 Class II Brandywine Pharmaceuticals, LLC
Drug
Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-501-10.
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory